It is noteworthy that JAK2 mutations occur more frequently in patients diagnosed with Ph-like ALL, a high-risk subtype characterized by gene expression patterns resembling Ph+ ALL, despite the absence of the chromosomal translocation t(9;22)(q34;q11) [58,59]. The gene discussed is JAK2; the disease is acute lymphoblastic leukemia.